Discussion The results of the current meta-analysis, that included 60,080 patients with T2DM, 14,804 of whom without established CV disease, demonstrate that GLP-1RA reduce the risk of MACE by 14% in the overall diabetic population, with an apparently greater effect in patients with known CV disease as compared with those without established CV disease (16% vs 6% reduction, respectively)
The post asks for the surgical history in detail, including the date of the cholecystectomy, any post-operative gastrointestinal symptoms, current symptoms, and the weight management goals being pursued
25C
GLP-1 agonists are widely used for weight management, and they have a good safety profile
While both peptides and anabolic steroids can influence hormone systems, they work very differently
10.1002/fsn3.4176 107 TreftsE.ShawR